Vγ9Vδ2TCR (30) and CD8αβ-independent αβTCRs (32) have been also reported to reprogram CD4+ T cells, which not only have the ability to exert tumor cell killing but also induce maturation of professional antigen-presenting cells. This evidence concerns the gene CD4 and neoplasm.